Acadia Pharmaceuticals | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
ALKERMES USD 390.7M 84.2M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Corcept Therapeutics USD 194.4M 37.2M 2025-06
Cytokinetics USD 66.76M 65.16M 2025-06
Eisai JPY 202.65B 14.41B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Incyte USD 1.06B 10M 2025-06
J&J USD 23.74B 1.85B 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Pfizer USD 14.7B 980M 2025-06
Prothena USD 2.12M 1.15M 2024-12
PTC Therapeutics USD 178.9M 11.1M 2025-06
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


Acadia Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.